Drugs / INH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT02169882 Background | Dec 2014 → Nov 2016 | meningeal tuberculosis | Padjadjaran University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INH | “other oral TB drugs (INH, Ethambutol, and Pyrazinamide) and pyridoxin” NCT02169882 ↗ |
| Route | Oral | “other oral TB drugs (INH, Ethambutol, and Pyrazinamide) and pyridoxin” NCT02169882 ↗ |